FindTrial
Sign In

Study of intraoperative dextrose and insulin infusion in liver donor patients

Effect of intraoperative dextrose infusion on postoperative hepatic functions in right living donor hepatectomy-randomised clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/021849
Enrollment
174
Registered
2019-11-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: 25% DEXTROSE: DEXTROSE AND INSULIN WILL BE ADMINISTERED INTRAOPERATIVELY AND ALL VALUES INTRAOPERATIVELY AND POSTOPERATIVELY WILL BE RECORDED BY PRINCIPAL INVESTIGATOR STUDY DURATION 1

Sponsors

INDRAPRASTHA APOLLO HOSPITALS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA GRADE I OR II PATIENTS OF EITHER SEX SCHEDULED FOR RIGHT LOBE DONOR HEPATECTOMY AGE 18-60 YEARS

Exclusion criteria

Exclusion criteria: Patient refusal Patient with uncontrolled blood sugars Patient with blood loss >1 litre Patient with remnant liver volume Patient with left lobe resection Patient whose duration of surgery is more than 14 hours Patient on beta blockers or calcium chanel blockers

Design outcomes

Primary

MeasureTime frame
LIVER FUNCTION TESTS ASSESSMENT ON INTRAOPERATIVE ADMINISTRATION OF DEXTROSETimepoint: LIVER FUNCTION TESTS POSTOPERATIVE DAY 7 INTRAOPERATIVE LACTATE DIFFERENCE—

Secondary

MeasureTime frame
TO ASSESS RENAL FUNCTION TESTTimepoint: postoperative day 7—

Countries

India

Contacts

Public ContactNIDHI SINHA

INDRAPRASTHA APOLLO HOSPITALS

raina.raman@gmail.com9958290493

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026